Essential thrombocytosis: diagnosis, differential diagnosis, complications and treatment considerations of relevance for a cardiologist

Essential thrombocytosis (ET) is a rare haematological malignancy, with an incidence rate of 1.5–2.5/100,000 per year. For many patients with ET the first manifestation of their underlying disease is a thrombotic or haemorrhagic complication. A recent retrospective study revealed an incidence rate o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuipers, R. S., Kok, L., Virmani, R., Tefferi, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516821/
https://www.ncbi.nlm.nih.gov/pubmed/36757576
http://dx.doi.org/10.1007/s12471-023-01757-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516821/
https://www.ncbi.nlm.nih.gov/pubmed/36757576
http://dx.doi.org/10.1007/s12471-023-01757-4

Ejemplares similares